Abstract
Th17 cells and their proinflammatory signature cytokine, IL-17, have recently replaced Th1 cells to be the essential Th effector population in autoimmune disease. This was based on a similar line of evidence that previously destined Th1 cells to be the sole encephalitogenic Th-cell effector type. However, as for the Th1-effector type before, an increasing amount of evidence is accumulating that questions the pivotal role of Th17 cells in autoimmunity. Recently, four high-impact articles were published that clearly show that Th1 and Th17 cells carry encephalitogenic properties, and dominance of either in an autoimmune setting can confer disease. In two mouse models for autoimmune neuroinflammation, it was suggested that Th1 and Th17 cells act in parallel, both exhibiting a different set of effector mechanisms.
References
Aug 6, 1998·European Journal of Immunology·H P EugsterA Fontana
Jul 6, 2000·Science·Z SunD R Littman
Aug 22, 2002·The Journal of Clinical Investigation·Burkhard BecherRandolph J Noelle
Mar 1, 2003·Nature·Daniel J CuaJonathon D Sedgwick
Dec 24, 2003·Nature Immunology·Gérard EberlDan R Littman
Jan 20, 2005·The Journal of Experimental Medicine·Claire L LangrishDaniel J Cua
Jan 3, 2006·Cellular Immunology·Harald H HofstetterRalf Gold
Jan 18, 2006·The Journal of Clinical Investigation·Jingsong WangLaurie H Glimcher
May 4, 2006·The Journal of Clinical Investigation·Yi ChenDaniel J Cua
Jun 21, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Yutaka KomiyamaYoichiro Iwakura
Sep 23, 2006·Cell·Ivaylo I IvanovDan R Littman
Nov 1, 2006·Critical Reviews in Immunology·Yoshiro Kobayashi
Dec 5, 2006·Trends in Immunology·Ingo BechmannV Hugh Perry
May 4, 2007·The Journal of Clinical Investigation·Ilona Gutcher, Burkhard Becher
Sep 4, 2007·Current Opinion in Immunology·Estelle BettelliVijay K Kuchroo
Sep 11, 2007·Nature Medicine·Hania KebirAlexandre Prat
Nov 13, 2007·Nature Immunology·Mandy J McGeachyDaniel J Cua
Feb 19, 2008·Nature Medicine·Ingunn M StromnesJoan M Goverman
Mar 19, 2008·The Journal of Experimental Medicine·Thaddeus CarlsonBenjamin Segal
Apr 9, 2008·The Journal of Experimental Medicine·Dror LugerRachel R Caspi
Apr 11, 2008·Immunity·Mandy J McGeachy, Daniel J Cua
Jun 25, 2008·The Journal of Experimental Medicine·Mark A KroenkeBenjamin M Segal
Jul 2, 2008·The Journal of Experimental Medicine·Lawrence Steinman
Aug 16, 2008·Lancet Neurology·Benjamin M SegalUNKNOWN Ustekinumab MS Investigators
Sep 5, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Richard A O'ConnorStephen M Anderton
Oct 23, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Jimmy W LeeDaniel S Straus
Citations
Jan 4, 2013·PloS One·Amber L RowsePatrizia De Sarno
Sep 27, 2013·PloS One·Jianqin HeLanjuan Li
Mar 25, 2011·Medicinal Research Reviews·Prakash ManikwarTeruna J Siahaan
Dec 12, 2012·International Journal for Parasitology·Elsenoor J KlaverIrma van Die
Jan 3, 2012·Neuropharmacology·Ahmed H BadawiTeruna J Siahaan
Feb 10, 2012·Immunopharmacology and Immunotoxicology·Farhad Jadidi-Niaragh, Abbas Mirshafiey
Dec 3, 2014·Immunology Letters·Yi ChenYong-Ping Chen
Sep 25, 2016·Autoimmunity Reviews·Gagandeep KaurShifali Singla
Nov 23, 2011·Toxicologic Pathology·Brad Bolon
Feb 28, 2020·Cells·Fei LiuWen Tan
Jan 20, 2016·The Journal of Immunology : Official Journal of the American Association of Immunologists·Katharine E BlockHaochu Huang